<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04997590</url>
  </required_header>
  <id_info>
    <org_study_id>YXLL-KY-2020(041)</org_study_id>
    <nct_id>NCT04997590</nct_id>
  </id_info>
  <brief_title>Clinical Study of Umbilical Cord Blood Mononuclear Cells (UCB-MNCs) in the Treatment of Traumatic Fracture Healing</brief_title>
  <official_title>Clinical Study of Umbilical Cord Blood Mononuclear Cells (UCB-MNCs) in Promoting Traumatic Fracture Healing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Qianfoshan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shandong Qilu Stem Cells Engineering Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Qianfoshan Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to explore the effectiveness and safety of umbilical cord blood&#xD;
      mononuclear cells in promoting traumatic fracture healing.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Umbilical cord blood mononuclear cells are a type of cell group containing hematopoietic stem&#xD;
      cells, mesenchymal stem cells, neural stem cells, endothelial cells, immune cells, etc.In&#xD;
      this study ,umbilical cord blood mononuclear cells will be used in promoting traumatic&#xD;
      fracture healing,and the effectiveness and safety of the treatment plan was evaluated by&#xD;
      twelve months of follow-up after treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 10, 2020</start_date>
  <completion_date type="Anticipated">December 10, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bone formation</measure>
    <time_frame>1 month to 1 year after treatment</time_frame>
    <description>If there is no bone formation, 0 points. Bone formation accounts for 25% of the fracture area, 1 point. Bone formation accounts for 50% of the fracture area, 2 points. Bone formation accounts for 75% of the fracture area, 3 points. Bone filled the gap between fracture ends, 4 points.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bone defect connection</measure>
    <time_frame>1 month to 1 year after treatment</time_frame>
    <description>0 points for complete fracture lines, 2 points for partial fracture lines, 4 points for lack of fracture lines.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bone reconstruction</measure>
    <time_frame>1 month to 1 year after treatment</time_frame>
    <description>0 points for no manifestations of reconstruction,2 points for intramedullary cavity can be reconstructed , and 4 points for the cortical bone can be completely reconstructed. A total score of 11 points or more achieves a good healing effect.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Bone Nonunion</condition>
  <arm_group>
    <arm_group_label>Umbilical cord blood mononuclear cells group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Umbilical cord blood mononuclear cells (cell number 1×108/2mL), once every two weeks, 3 times in total.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Staphylococcal Enterotoxin C group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Staphylococcal enterotoxin C (2mL), once every two weeks, 3 times in total.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Umbilical cord blood mononuclear cells</intervention_name>
    <description>injection of CB-MNCs (cell count 1×108 cells/time) was performed once every 2 week for a total of 3 times.</description>
    <arm_group_label>Umbilical cord blood mononuclear cells group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Staphylococcal Enterotoxin C</intervention_name>
    <description>injection of staphylococcal enterotoxin C was performed once every 2 week for a total of 3 times.</description>
    <arm_group_label>Staphylococcal Enterotoxin C group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Traumatic long bone fracture.&#xD;
&#xD;
          -  Noninfectious bone nonunion, delayed bone union.&#xD;
&#xD;
          -  3 months after the operation of the fracture, the examination showed no callus growth,&#xD;
             no signs of progressive repair at the fracture site, fracture piece space &lt; 5mm.&#xD;
&#xD;
          -  No shortening, angulation and displacement.&#xD;
&#xD;
          -  There was no obvious callus growth 8 months after local bone grafting.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  There are infection foci at and near the fracture end after fracture.&#xD;
&#xD;
          -  3 months after the fracture, tests showed partial callus growth.&#xD;
&#xD;
          -  Combining shortening, angulation and displacement phenomena.&#xD;
&#xD;
          -  Partial callus grew 8 months after local bone grafting.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jing Liang, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shandong Provincial Qianfoshan Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chunming Zhang, doctor</last_name>
    <phone>+8618663761275</phone>
    <email>liangjing0531@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>China, Shandong Qianfoshan Hospital</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250014</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lili Cao</last_name>
      <email>qykyc309@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 26, 2021</study_first_submitted>
  <study_first_submitted_qc>August 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2021</study_first_posted>
  <last_update_submitted>August 2, 2021</last_update_submitted>
  <last_update_submitted_qc>August 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Qianfoshan Hospital</investigator_affiliation>
    <investigator_full_name>Lili Cao</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Umbilical cord blood mononuclear cells</keyword>
  <keyword>Traumatic fracture healing</keyword>
  <keyword>Bone nonunion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

